Hepatitis B Virus Treatment and Hepatocellular Carcinoma: Controversies and Approaches to Consensus

Soo Ki Kim; Takako Fujii; Soo Ryang Kim; Atsushi Nakai; Young‐Suk Lim; Satoru Hagiwara; Masatoshi Kudo

doi:10.1159/000525518

Article2019

Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh A Liver Function: A Proof-Of-Concept Study

Masatoshi Kudo, Kazuomi Ueshima, Stephan Chan, Tomohiro Minami, Hirokazu Chishina, Tomoko Aoki, Masahiro Takita, Satoru Hagiwara, Yasunori Minami, Hiroshi Ida, Mamoru Takenaka, Toshiharu Sakurai, Tomohiro Watanabe, Masahiro Morita, Chikara Ogawa, Yoshiyuki Wada, Masafumi Ikeda, Hiroshi Ishii, Namiki Izumi, Naoshi Nishida

Preprint2019

Lenvatinib as an Initial Treatment in Patients with Intermediate-stage Hepatocellular Carcinoma Beyond up-to-seven Criteria and Child-Pugh A Liver Function: A Proof-of-Concept Study

Masatoshi Kudo, Kazuomi Ueshima, Stephan Chan, Tomohiro Minami, Hirokazu Chishina, Tomoko Aoki, Masahiro Takita, Satoru Hagiwara, Yasunori Minami, Hiroshi Ida, Mamoru Takenaka, Toshiharu Sakurai, Tomohiro Watanabe, Masahiro Morita, Chikara Ogawa, Yoshiyuki Wada, Masafumi Ikeda, Hiroshi Ishii, Namiki Izumi, Naoshi Nishida

Article2016

A Novel Non-Pharmaceutical Treatment for Patients with Mild Cognitive Impairment

Christina Darviri, Chrysa Zavitsanou, Aikaterini Delikou, Aikaterini Giotaki, Artemios Artemiadis, Aspasia Terentiou, George Chrousos

Article2015

Absorb Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent in ST-Segment Elevation Myocardial Infarction: 1-Year Results of a Propensity Score Matching Comparison

Salvatore Brugaletta, Tommaso Gori, Adrian F. Low, Petr Toušek, Eduardo Pinar, Josep Gómez‐Lara, Giancarla Scalone, Eberhard Schulz, Mark Y. Chan, Viktor Kočka, José Hurtado, Juan Antoni Gomez-Hospital, Thomas Münzel, Chi‐Hang Lee, Ángel Cequier, Mariano Valdés, Petr Widimský, Patrick W. Serruys, Manel Sabaté

КАРДИОЛОГИЯ УЗБЕКИСТАНА

Article2020

Initial lenvatinib therapy with no prior TACE in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria and Child-Pugh A liver function: A proof-of-concept study.

Masatoshi Kudo, Kazuomi Ueshima, Stephen L. Chan, Tomoko Aoki, Satoru Hagiwara, Yasunori Minami, Hiroshi Ida, Mamoru Takenaka, Tomohiro Watanabe, Masahiro Morita, Chikara Ogawa, Yoshiyuki Wada, Masafumi Ikeda, Hiroshi Ishii, Namiki Izumi, Atsushi Hiraoka, Hiroshi Aikata, Naoshi Nishida

Hepatitis B Virus Treatment and Hepatocellular Carcinoma: Controversies and Approaches to Consensus

Abstract

Discussion(0)

Related publications

Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh A Liver Function: A Proof-Of-Concept Study

Lenvatinib as an Initial Treatment in Patients with Intermediate-stage Hepatocellular Carcinoma Beyond up-to-seven Criteria and Child-Pugh A Liver Function: A Proof-of-Concept Study

A Novel Non-Pharmaceutical Treatment for Patients with Mild Cognitive Impairment

Absorb Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent in ST-Segment Elevation Myocardial Infarction: 1-Year Results of a Propensity Score Matching Comparison

Initial lenvatinib therapy with no prior TACE in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria and Child-Pugh A liver function: A proof-of-concept study.